Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 3, 2005, Pages 409-417

  Ennis, Darren P ^a   Cassidy, Joseph P ^b   Mahon, Bernard P ^a,c  

^a Institute of Immunology   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; METHACHOLINE; OVALBUMIN; PERTUSSIS VACCINE; INTERLEUKIN DERIVATIVE;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BORDETELLA PERTUSSIS; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EXPOSURE; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; LUNG FUNCTION; MASS IMMUNIZATION; MOUSE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SENSITIZATION; WILD TYPE; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; IMMUNOLOGY; PERTUSSIS;

ANIMALS; ASTHMA; BORDETELLA PERTUSSIS; BRONCHIAL HYPERREACTIVITY; FEMALE; INTERLEUKINS; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OVALBUMIN; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 23844477662     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.3.409-417.2005     Document Type: Article

References (62)

1. Ausiello, C. M., F. Urbani, A. la Sala, R. Lande, and A. Cassone. 1997. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:2168-2174.
2. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and K. H. G. Mills. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T cell subsets as Th1, Th2 or Th0. Immunology 87:372-380.
3. Blumberg, D. A., K. Lewis, C. M. Mink, P. D. Christenson, P. Chatfield, and J. D. Cherry. 1993. Severe reactions associated with diphtheria-tetanus- pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Pediatrics 91:1158-1165.
4. Bousquet, J., and P. Burney. 1993. Evidence for an increase in atopic disease and possible causes. Clin. Exp. Allergy 23:484-492.
5. Burr, M. L., B. K. Butland, S. King, and E. Vaughan-Williams. 1989. Changes in asthma prevalence: two surveys 15 years apart. Arch. Dis. Child. 64:1452-1456.
6. Donnelly, S., C. E. Loscher, M. A. Lynch, and K. H. Mills. 2001. Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1β in a new murine model for analysis of neuronal side effects of vaccination. Infect. Immun. 69:4217-4223.
7. Ennis, D. P., J. P. Cassidy, and B. P. Mahon. 2004. Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma, Immunol. Lett. 10.1016/j.imlet2004.10.011.
8. Ennis, D. P., J. P. Cassidy, and B. P. Mahon. 2004. Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma. Clin. Exp. Allergy 34:1488-1497.
9. Erb, K. J. 1999. Atopic disorders: a default pathway in the absence of infection? Immunol. Today 20:317-322.
10. Farooqi, I. S., and J. M. Hopkin. 1998. Early childhood infection and atopic disorder. Thorax 53:927-932.
11. Greco, D. D., S. Salmaso, P. Mastrantonio, et al. 1996. A controlled trial of two acellular vaccines and one whole cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
12. Gruber, C., L. Susanne, W. Ulrich, et al. 2003. Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics 111:282-287.
13. Grunstein, M. M., H. Hakonarson, J. Leiter, M. Chen, R. Whelan, J. S. Grunstein, and S. Chuang. 2001. Autocrine signaling by IL-10 mediates altered responsiveness of atopic sensitized airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L1130-L1137.
14. Haahtela, T., H. Lindholm, F. Bjorksten, K. Koskenvuo, and L. A. Laitinen. 1990. Prevalence of asthma in Finnish young men. BMJ 301:266-268.
15. Haczku, A., K. Takeda, E. Hamelmann, A. Oshiba, J. Loader, A. Joetham, C. Irvin, H. Kikutani, and E. W. Gelfand. 1997. CD23 deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalbumin. Am. J. Respir. Crit. Care Med. 156:1945-1955.
16. Hamelmann, E., K. Takeda, J. Schwarze, A. T. Vella, C. G. Irvin, and E. W. Gelfand. 1999. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am. J. Respir. Cell Mol. Biol. 21:480-489.
17. Hedenskog, S., B. Bjorksten, M. Blennow, G. Granstrom, and M. Granstrom. 1989. Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine. Int. Arch. Allergy Appl. Immunol. 89:156-161.
18. Henderson, J., K. North, J. Golding, et al. 1999. Pertussis vaccination and wheezing illnesses in young children: prospective cohort study. BMJ 318:1173-1176.
19. Higgins, S. C., E. C. Lavelle, C. McCann, B. Keogh, E. McNeela, P. Byrne, B. O'Gorman, A. Jarnicki, P. McGuirk, and K. H. G. Mills. 2003. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171:3119-3127.
20. Holgate, S. T., P. Lackie, S. Wilson, W. Roche, and D. Davies. 2000. Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. Am. J. Respir. Crit. Care Med. 162:S113-S117.
21. Hurwitz, E. L., and H. Morgenstern. 2000. Effects of diphtheria-tetanus- pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J. Manipulative Physiol. Ther. 23:81-90.
22. Ingram, J. L., A. B. Rice, K. Geisenhoffer, D. K. Madtes, and J. C. Bonner. 2004. IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha. FASEB J. 18:1132-1134.
23. Izuhara, K., K. Arima, and S. Yasunaga. 2002. IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies. Curr. Drug Targets Inflamm. Allergy 1:263-269.
24. Johnson, T. R., and B. S. Graham. 1999. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism. J. Virol. 73:8485-8495.
25. Lee, C. G., R. J. Homer, J. A. Elias, et al. 2002. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodelling via IL-13-dependent and -independent pathways. J. Biol. Chem. 277:35466-35474.
26. Lindsay, D. S., R. Parton, and A. C. Wardlaw. 1994. Adjuvant effect of pertussis toxin on the production of anti-ovalbumin IgE in mice and lack of direct correlation between PCA and ELISA. Int. Arch. Allergy Immunol. 105:281-288.
27. Mahon, B. P., M. T. Brady, and K. H. Mills. 2000. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J. Infect. Dis. 181:2087-2091.
28. Mahon, B. P., M. Ryan, F. Griffin, P. McGuirk, and K. H. G. Mills. 1996. IL-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting the induction of Th1 cells. Infect. Immun. 64:5295-5301.
29. Mahon, B. P., B. J. Sheahan, F. Griffin, G. Murphy, and K. H. G. Mills. 1997. Bordetella pertussis respiratory infection of mice with targeted disruptions of the genes coding for the interferon-g receptor or immunoglobulin results in atypical disease. J. Exp. Med. 186:1843-1851.
30. Matsuse, H., A. K. Behera, M. Kumar, H. Rabb, R. F. Lockey, and S. S. Mohapatra. 2000. Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J. Immunol. 164:6583-6592.
31. McGuirk, P., C. McCann, and K. H. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:221-231.
32. McGuirk, P., and K. H. G. Mills. 2000. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous haemagglutinin from Bordetella pertussis. Eur. J. Immunol. 30:415-422.
33. McGuirk, P., and K. H. G. Mills. 2000. A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines. Infect. Immun. 68:1383-1390.
34. Miller, E., M. Rush, L. A. Ashworth, T. J. Coleman, J. Rossini, O. A. Ahmed, S. Lingam, and M. E. Ramsay. 1995. Antibody responses and reactions to the whole cell pertussis component of a combined diphtheria/tetanus/pertussis vaccine given at school entry. Vaccine 13:1183-1186.
35. Mills, K. H. G., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
36. Mills, K. H. G., M. Brady, E. J. Ryan, and B. P. Mahon. 1998. A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in the definition of the mechanism of protective immunity. Dev. Biol. Stand. 95:31-41.
37. Mills, K. H. G., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602.
38. Moore, P. E., T. L. Church, D. D. Chism, R. A. Panettieri, Jr., and S. A. Shore. 2002. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L847-L853.
39. Mu, H. H., and W. A. Sewell. 1994. Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin. Immunology 83:639-645.
40. Nilsson, L., C. Gruber, M. Granstrom, B. Bjorksten, and N. I. Kjellman. 1998. Pertussis IgE and atopic disease. Allergy 53:1195-1201.
41. Nilsson, L., N. I. Kjellman, and B. Bjorksten. 1998. A randomized controlled trial of the effect of pertussis vaccines on atopic disease. Arch. Pediatr. Adolesc. Med. 152:734-738.
42. Odelram, H., M. Granstrom, S. Hedenskog, K. Duchen, and B. Bjorksten. 1994. Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminium content of the vaccines. Pediatr. Allergy Immunol. 5:118-123.
43. Odent, M., and E. Culpin. 2003. Effect of immunisation status on asthma prevalence. Lancet 361:434.
44. Olin, P., L. Gustafsson, L. Barreto, L. Hessel, T. C. Mast, A. V. Rie, H. Bogaerts, and J. Storsaeter. 2003. Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine. Vaccine 21:2015-2021.
45. Pauwels, R., M. Van der Straeten, B. Platteau, and H. Bazin. 1983. The non-specific enhancement of allergy. I. In vivo effects of Bordetella pertussis vaccine on IgE synthesis. Allergy 38:239-246.
46. Peat, J. K. 1998. Can asthma be prevented? Evidence from epidemiological studies of children in Australia and New Zealand in the last decade. Clin. Exp. Allergy 28:261-265.
47. Peat, J. K. 1994. The rising trend in allergic illness: which environmental factors are important? Clin. Exp. Allergy 24:797-800.
48. Rook, G., and A. Zumla. 1997. Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? Lancet 349:1831-1833.
49. Rook, G. A., and J. L. Stanford. 1998. Give us this day our daily germs. Immunol. Today 19:113-116.
50. Ryan, E. J., L. Nilsson, N. Kjellman, L. Gothefors, and K. H. Mills. 2000. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin. Exp. Immunol. 121:193-200.
51. Ryan, M., L. McCarthy, B. P. Mahon, R. Rappuoli, and K. H. G. Mills. 1998. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the costimulatory molecules B7-1, B7-2 and CD28. Int. Immunol. 10:651-662.
52. Ryan, M., G. Murphy, E. Ryan, L. Nilsson, F. Shackley, L. Gothefors, K. Oymar, E. Miller, J. Storsaeter, and K. H. G. Mills. 1998. Distinct Th cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93:1-10.
53. Ryan, M. S., F. Griffin, B. P. Mahon, and K. H. G. Mills. 1997. The role of the S-1 and B-oligomer components of pertussis toxin in its adjuvant properties for Th1 and Th2 cells. Biochem. Soc. Trans. 25:124.
54. Salmaso, S., P. Mastrantonio, S. G. Wassilak, M. Giuliano, A. Anemona, A. Giammanco, A. E. Tozzi, M. L. Ciofi degli Atti, and D. Greco. 1998. Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Vaccine 16:1270-1275.
55. Shaheen, S. O. 1995. Changing patterns of childhood infection and the rise in allergic disease. Clin. Exp. Allergy 25:1034-1037.
56. von Mutius, E. 2002. Environmental factors influencing the development and progression of pediatric asthma. J. Allergy Clin. Immunol. 109:S525-S532.
57. von Mutius, E., F. D. Martinez, C. Fritzsch, T. Nicolai, G. Roell, and H. H. Thiemann. 1994. Prevalence of asthma and atopy in two areas of West and East Germany. Am. J. Respir. Crit. Care Med. 149:358-364.
58. Wei, L. H., A. T. Jacobs, S. M. J. Morris, and L. J. Ignarro. 2000. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am. J. Physiol. 279:C248-C256.
59. Wilder, J. A., D. D. Collie, B. S. Wilson, D. E. Bice, C. R. Lyons, and M. F. Lipscomb. 1999. Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 20:1326-1334.
60. Yazdanbakhsh, M., P. G. Kremsner, and R. van Ree. 2002. Allergy, parasites, and the hygiene hypothesis. Science 296:490-494.
61. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 158:3539-3544.
62. Zuany-Amorim, C., E. Sawicka, C. Manlius, A. Le Moine, L. R. Brunet, D. M. Kemeny, G. Bowen, G. Rook, and C. Walker. 2002. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8:625-629.